Intercept to Announce Third Quarter 2021 Financial Results on November 3, 2021
27 October 2021 - 11:00PM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a
biopharmaceutical company focused on the development and
commercialization of novel therapeutics to treat progressive
non-viral liver diseases, will announce its third quarter 2021
financial results prior to market open on Wednesday, November 3,
2021. The announcement will be followed by a conference call and
audio webcast hosted by Intercept management at 8:30 a.m. ET to
discuss the results.
The conference call will be available on the investor page of
our website at http://ir.interceptpharma.com or by calling (855)
232-3919 (toll-free domestic) or (315) 625-6894 (international)
passcode 6266006. Archived webcasts will be available on
Intercept’s website for approximately two weeks.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC) and nonalcoholic
steatohepatitis (NASH). Founded in 2002 in New York, Intercept
has operations in the United
States, Europe and Canada. For more information,
please visit www.interceptpharma.com or connect with the
company on Twitter and LinkedIn.
CONTACT
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Jul 2023 to Jul 2024